نتایج جستجو برای: myeloablative

تعداد نتایج: 1963  

Journal: :Haematologica 2010
Emilio Paolo Alessandrino Matteo Giovanni Della Porta Andrea Bacigalupo Luca Malcovati Emanuele Angelucci Maria Teresa Van Lint Michele Falda Francesco Onida Massimo Bernardi Stefano Guidi Barbarella Lucarelli Alessandro Rambaldi Raffaella Cerretti Paola Marenco Pietro Pioltelli Cristiana Pascutto Rosi Oneto Laura Pirolini Renato Fanin Alberto Bosi

BACKGROUND Transfusion-dependency affects the natural history of myelodysplastic syndromes. Secondary iron overload may concur to this effect. The relative impact of these factors on the outcome of patients with myelodysplastic syndrome receiving allogeneic stem-cell transplantation remains to be clarified. DESIGN AND METHODS We retrospectively evaluated the prognostic effect of transfusion h...

2002
Christian Junghanss Michael Boeckh Rachel A. Carter Brenda M. Sandmaier Michael B. Maris David G. Maloney Thomas Chauncey Peter A. McSweeney Rainer Storb

Nonmyeloablative allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly being explored as therapy in patients who are not eligible for conventional myeloablative HSCT. Whether these transplants are associated with reduced risk of transplantation-related infections is unknown. We analyzed the incidence of posttransplantation cytomegalovirus (CMV) infections in 56 consecutive m...

Journal: :Blood 1991
S Siena M Bregni B Brando N Belli F Ravagnani L Gandola A C Stern P M Lansdorp G Bonadonna A M Gianni

Optimum methods of harvesting circulating hematopoietic progenitors for autologous transplantation to support myeloablative cancer therapy are still uncertain, mostly because of the lack of an assay for marrow-repopulating stem cells. The CFU-GM assay, the commonly used indirect indicator of the quality of the graft, is poorly standardized and provides results evaluable only retrospectively. Ba...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008
Anna Sureda Stephen Robinson Carmen Canals Angelo M Carella Marc A Boogaerts Dolores Caballero Ann E Hunter Lothar Kanz Shimon Slavin Jan J Cornelissen Martin Gramatzki Dietger Niederwieser Nigel H Russell Norbert Schmitz

PURPOSE To compare the clinical outcome in terms of nonrelapse mortality (NRM), relapse rate (RR), overall survival (OS), and progression-free survival (PFS) in patients with relapsed Hodgkin's lymphoma (HL) treated with reduced-intensity conditioning (RIC) or myeloablative conditioning followed by allogeneic stem-cell transplantation (alloSCT). PATIENTS AND METHODS A total of 168 patients wi...

2017
Ben Nasr

Mobilized peripheral blood stem cells (MPBSC) have nearly replaced bone marrow (BM). So, they become the primary source of hematopoietic grafts especially for patients with hematological malignancies undergoing aggressive myelosuppressive or myeloablative chemotherapy. It allows faster engraftment and equivalent disease-free survival compared with bone marrow cells [Siena S et al, 2000; To LB e...

2002
Gregory A. Yanik John E. Levine Katherine K. Matthay James C. Sisson Barry L. Shulkin Brahm Shapiro David Hubers Susan Spalding Tom Braun Raymond J. Hutchinson

Purpose: The survival for children with relapsed or metastatic neuroblastoma remains poor. More effective regimens with acceptable toxicity are required to improve prognosis. Iodine-131–metaiodobenzylguanidine (131I-MIBG) selectively targets radiation to catecholamine-producing cells, including neuroblastoma cells. A pilot study was performed to examine the feasibility of a novel regimen combin...

Journal: :Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009
Katherine K Matthay C Patrick Reynolds Robert C Seeger Hiroyuki Shimada E Stanton Adkins Daphne Haas-Kogan Robert B Gerbing Wendy B London Judith G Villablanca

UNLABELLED PURPOSE We assessed the long-term outcome of patients enrolled on CCG-3891, a high-risk neuroblastoma study in which patients were randomly assigned to undergo autologous purged bone marrow transplantation (ABMT) or to receive chemotherapy, and subsequent treatment with 13-cis-retinoic acid (cis-RA). PATIENTS AND METHODS Patients received the same induction chemotherapy, with random ...

Journal: :Haematologica 2007
Pieter Sonneveld Bronno van der Holt Christine M Segeren Edo Vellenga Alexandra J Croockewit Gregor E G Verhoe Jan J Cornelissen Martijn R Schaafsma Marinus H J van Oers Pierre W Wijermans Petra H M Westveer Henk M Lokhorst

BACKGROUND AND OBJECTIVES The Dutch-Belgian HOVON group performed a randomized phase 3 trial to compare single non-myeloablative intensive treatment with double, intensive treatment in previously untreated patients with multiple myeloma (MM). DESIGN AND METHODS Three hundred and three patients with stage II/III MM were randomized after VAD induction chemotherapy to receive two cycles of non-m...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید